Pacer Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $815K | Buy |
2,925
+30
| +1% | +$8.64K | ﹤0.01% | 1295 |
|
|
2025
Q4 | $877K | Sell |
2,895
-809
| -22% | -$252K | ﹤0.01% | 1533 |
|
|
2025
Q3 | $1.04M | Buy |
3,704
+2,279
| +160% | +$620K | ﹤0.01% | 1409 |
|
|
2025
Q2 | $344K | Buy |
+1,425
| New | +$337K | ﹤0.01% | 1544 |
|
|
2025
Q1 | – | Sell |
-2,782
| Closed | -$914K | – | 3651 |
|
|
2024
Q4 | $914K | Sell |
2,782
-30
| -1% | -$10.2K | ﹤0.01% | 1404 |
|
|
2024
Q3 | $941K | Buy |
2,812
+233
| +9% | +$74K | ﹤0.01% | 1415 |
|
|
2024
Q2 | $704K | Buy |
2,579
+1,124
| +77% | +$327K | ﹤0.01% | 1467 |
|
|
2024
Q1 | $503K | Buy |
1,455
+38
| +3% | +$12.5K | ﹤0.01% | 1545 |
|
|
2023
Q4 | $458K | Sell |
1,417
-2,925
| -67% | -$917K | ﹤0.01% | 1554 |
|
|
2023
Q3 | $1.56M | Buy |
4,342
+624
| +17% | +$241K | 0.01% | 664 |
|
|
2023
Q2 | $1.41M | Buy |
3,718
+1,766
| +90% | +$719K | 0.01% | 884 |
|
|
2023
Q1 | $935K | Buy |
1,952
+1,595
| +447% | +$747K | ﹤0.01% | 963 |
|
|
2022
Q4 | $150K | Sell |
357
-1,042
| -74% | -$421K | ﹤0.01% | 2411 |
|
|
2022
Q3 | $584K | Buy |
1,399
+90
| +7% | +$44.9K | ﹤0.01% | 697 |
|
|
2022
Q2 | $648K | Sell |
1,309
-780
| -37% | -$406K | ﹤0.01% | 630 |
|
|
2022
Q1 | $1.18M | Buy |
2,089
+931
| +80% | +$561K | 0.01% | 834 |
|
|
2021
Q4 | $875K | Sell |
1,158
-834
| -42% | -$624K | 0.01% | 1293 |
|
|
2021
Q3 | $1.49M | Sell |
1,992
-309
| -13% | -$231K | 0.02% | 749 |
|
|
2021
Q2 | $1.48M | Buy |
2,301
+1,085
| +89% | +$660K | 0.02% | 699 |
|
|
2021
Q1 | $695K | Sell |
1,216
-195
| -14% | -$115K | 0.01% | 914 |
|
|
2020
Q4 | $823K | Sell |
1,411
-1,106
| -44% | -$630K | 0.02% | 782 |
|
|
2020
Q3 | $1.3M | Sell |
2,517
-388
| -13% | -$197K | 0.03% | 597 |
|
|
2020
Q2 | $1.31M | Buy |
2,905
+2,873
| +8,978% | +$1.27M | 0.03% | 487 |
|
|
2020
Q1 | $14K | Sell |
32
-7,309
| -100% | -$2.69M | ﹤0.01% | 590 |
|
|
2019
Q4 | $2.72M | Sell |
7,341
-427
| -5% | -$151K | 0.12% | 175 |
|
|
2019
Q3 | $2.58M | Sell |
7,768
-284
| -4% | -$92.6K | 0.06% | 379 |
|
|
2019
Q2 | $2.52M | Buy |
8,052
+8,012
| +20,030% | +$2.4M | 0.06% | 365 |
|
|
2019
Q1 | $12K | Sell |
40
-47
| -54% | -$12.7K | ﹤0.01% | 718 |
|
|
2018
Q4 | $20K | Sell |
87
-7,165
| -99% | -$1.92M | ﹤0.01% | 386 |
|
|
2018
Q3 | $2.27M | Buy |
7,252
+848
| +13% | +$263K | 0.09% | 285 |
|
|
2018
Q2 | $1.85M | Buy |
6,404
+871
| +16% | +$240K | 0.08% | 304 |
|
|
2018
Q1 | $1.38M | Buy |
5,533
+666
| +14% | +$170K | 0.08% | 332 |
|
|
2017
Q4 | $1.16M | Buy |
4,867
+1,096
| +29% | +$266K | 0.08% | 349 |
|
|
2017
Q3 | $838K | Buy |
3,771
+465
| +14% | +$105K | 0.07% | 382 |
|
|
2017
Q2 | $748K | Buy |
3,306
+471
| +17% | +$103K | 0.07% | 382 |
|
|
2017
Q1 | $565K | Buy |
2,835
+687
| +32% | +$132K | 0.07% | 426 |
|
|
2016
Q4 | $392K | Buy |
2,148
+207
| +11% | +$35.3K | 0.06% | 533 |
|
|
2016
Q3 | $318K | Buy |
1,941
+168
| +9% | +$25.5K | 0.05% | 573 |
|
|
2016
Q2 | $254K | Buy |
+1,773
| New | +$253K | 0.04% | 672 |
|
Other funds holding BIO
VCM
VPM
AI
